Financhill
Sell
27

ABUS Quote, Financials, Valuation and Earnings

Last price:
$3.20
Seasonality move :
21.65%
Day range:
$3.16 - $3.26
52-week range:
$2.21 - $4.73
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
85.85x
P/B ratio:
5.69x
Volume:
3M
Avg. volume:
922.9K
1-year change:
45.25%
Market cap:
$608.3M
Revenue:
$18.1M
EPS (TTM):
-$0.43

Arbutus Biopharma SEC Filings

Company Filed Form Type Description
ABUS
Arbutus Biopharma
11/07/2023 10-Q 10-Q filing on 11/07/2023 View Form
ABUS
Arbutus Biopharma
08/03/2023 10-Q 10-Q filing on 08/03/2023 View Form
ABUS
Arbutus Biopharma
05/04/2023 10-Q 10-Q filing on 05/04/2023 View Form
ABUS
Arbutus Biopharma
11/09/2022 10-Q 10-Q filing on 11/09/2022 View Form
ABUS
Arbutus Biopharma
08/04/2022 10-Q 10-Q filing on 08/04/2022 View Form
ABUS
Arbutus Biopharma
05/05/2022 10-Q 10-Q filing on 05/05/2022 View Form
ABUS
Arbutus Biopharma
11/04/2021 10-Q 10-Q filing on 11/04/2021 View Form
ABUS
Arbutus Biopharma
08/05/2021 10-Q 10-Q filing on 08/05/2021 View Form
ABUS
Arbutus Biopharma
05/05/2021 10-Q 10-Q filing on 05/05/2021 View Form
ABUS
Arbutus Biopharma
11/05/2020 10-Q 10-Q filing on 11/05/2020 View Form
ABUS
Arbutus Biopharma
08/07/2020 10-Q 10-Q filing on 08/07/2020 View Form
ABUS
Arbutus Biopharma
05/11/2020 10-Q 10-Q filing on 05/11/2020 View Form
ABUS
Arbutus Biopharma
03/06/2020 10-K 10-K filing on 03/06/2020 View Form
ABUS
Arbutus Biopharma
03/05/2020 10-K 10-K filing on 03/05/2020 View Form
ABUS
Arbutus Biopharma
11/06/2019 10-Q 10-Q filing on 11/06/2019 View Form
ABUS
Arbutus Biopharma
08/05/2019 10-Q 10-Q filing on 08/05/2019 View Form
ABUS
Arbutus Biopharma
05/06/2019 10-Q 10-Q filing on 05/06/2019 View Form
ABUS
Arbutus Biopharma
03/07/2019 10-K 10-K filing on 03/07/2019 View Form
ABUS
Arbutus Biopharma
11/07/2018 10-Q 10-Q filing on 11/07/2018 View Form
ABUS
Arbutus Biopharma
08/03/2018 10-Q 10-Q filing on 08/03/2018 View Form
ABUS
Arbutus Biopharma
05/04/2018 10-Q 10-Q filing on 05/04/2018 View Form
ABUS
Arbutus Biopharma
03/16/2018 10-K 10-K filing on 03/16/2018 View Form
ABUS
Arbutus Biopharma
11/02/2017 10-Q 10-Q filing on 11/02/2017 View Form
ABUS
Arbutus Biopharma
08/03/2017 10-Q 10-Q filing on 08/03/2017 View Form
ABUS
Arbutus Biopharma
05/17/2017 10-K 10-K filing on 05/17/2017 View Form
ABUS
Arbutus Biopharma
05/04/2017 10-Q 10-Q filing on 05/04/2017 View Form
ABUS
Arbutus Biopharma
03/22/2017 10-K 10-K filing on 03/22/2017 View Form
ABUS
Arbutus Biopharma
12/22/2016 10-Q 10-Q filing on 12/22/2016 View Form
ABUS
Arbutus Biopharma
11/03/2016 10-Q 10-Q filing on 11/03/2016 View Form
ABUS
Arbutus Biopharma
08/04/2016 10-Q 10-Q filing on 08/04/2016 View Form
ABUS
Arbutus Biopharma
05/04/2016 10-Q 10-Q filing on 05/04/2016 View Form
ABUS
Arbutus Biopharma
03/11/2016 10-K 10-K filing on 03/11/2016 View Form
ABUS
Arbutus Biopharma
03/09/2016 10-K 10-K filing on 03/09/2016 View Form
ABUS
Arbutus Biopharma
11/05/2015 10-Q 10-Q filing on 11/05/2015 View Form
ABUS
Arbutus Biopharma
08/07/2015 10-Q 10-Q filing on 08/07/2015 View Form
ABUS
Arbutus Biopharma
07/15/2015 10-Q 10-Q filing on 07/15/2015 View Form
ABUS
Arbutus Biopharma
05/06/2015 10-Q 10-Q filing on 05/06/2015 View Form
ABUS
Arbutus Biopharma
05/01/2015 10-K 10-K filing on 05/01/2015 View Form
ABUS
Arbutus Biopharma
03/13/2015 10-K 10-K filing on 03/13/2015 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock